BBC News
Two so-called "party" drugs and a man-made cannabis substitute will be banned by the end of the year, the Home Office has announced.
More Info
Subscribe To
Posts
All Comments
Showing posts with label Drugs. Show all posts
Showing posts with label Drugs. Show all posts
Friday, 28 August 2009
Monday, 22 June 2009
2009 Annual evidence update – Drugs – Drugs misuse treatment in offender populations
NHS Evidence
This evidence update covers drugs misuse treatments in the offender population. As it is the first AEU, the period it covers is wider. Evidence is presented from January 2005 to March 2009.
More Info
This evidence update covers drugs misuse treatments in the offender population. As it is the first AEU, the period it covers is wider. Evidence is presented from January 2005 to March 2009.
More Info
Tuesday, 10 March 2009
New mapping tool to tackle drug addiction
NHS National Treatment Agency for Substance Misuse
A pioneering new tool for drug workers and clinicians to promote behaviour change in drug-dependent clients is endorsed today (19 February 2009) by the National Treatment Agency for Substance Misuse (NTA). Extensive research has shown that this easy-to-use and innovative technique – which enables drug workers to visually represent their clients’ thinking in a series of personal maps – improves the engagement and motivation of drug misusers.
More Details
A pioneering new tool for drug workers and clinicians to promote behaviour change in drug-dependent clients is endorsed today (19 February 2009) by the National Treatment Agency for Substance Misuse (NTA). Extensive research has shown that this easy-to-use and innovative technique – which enables drug workers to visually represent their clients’ thinking in a series of personal maps – improves the engagement and motivation of drug misusers.
More Details
Monday, 9 March 2009
The Primary Prevention of Hepatitis C among Injecting Drug Users
Advisory Council on the Misuse of Drugs
Hepatitis C is a significant public health issue. It has been estimated that in 2003 in England and
Wales there were around 190,000 individuals infected with the hepatitis C virus (HCV). It is likely that over 80 per cent of current HCV infections are due to injecting drugs and that around 50 per cent of injecting drug users (IDU) in the UK are infected with HCV. Moreover, of those IDU who are infected, approximately half may be unaware that they are HCV positive. It is likely that HCV prevalence fell during the early and mid 1990s, but the trends have now reversed and among recent IDU HCV prevalence almost doubled between 1998 and 2007.
These statistics are set against a backdrop of an expansion of diagnostic and treatment services as part of the HCV Strategy and HCV Action Plan in England and the HCV Action Plan in Scotland.
In reviewing the evidence, we conclude that a single intervention may not, alone, be sufficient to
prevent the spread of the hepatitis C virus. The evidence suggests that the most effective way of
reducing HCV incidence among active IDUs is through a combination of Opiate Substitution Therapy (OST) and the provision of Needle and Syringe Programmes (NSP).
Full Article
Hepatitis C is a significant public health issue. It has been estimated that in 2003 in England and
Wales there were around 190,000 individuals infected with the hepatitis C virus (HCV). It is likely that over 80 per cent of current HCV infections are due to injecting drugs and that around 50 per cent of injecting drug users (IDU) in the UK are infected with HCV. Moreover, of those IDU who are infected, approximately half may be unaware that they are HCV positive. It is likely that HCV prevalence fell during the early and mid 1990s, but the trends have now reversed and among recent IDU HCV prevalence almost doubled between 1998 and 2007.
These statistics are set against a backdrop of an expansion of diagnostic and treatment services as part of the HCV Strategy and HCV Action Plan in England and the HCV Action Plan in Scotland.
In reviewing the evidence, we conclude that a single intervention may not, alone, be sufficient to
prevent the spread of the hepatitis C virus. The evidence suggests that the most effective way of
reducing HCV incidence among active IDUs is through a combination of Opiate Substitution Therapy (OST) and the provision of Needle and Syringe Programmes (NSP).
Full Article
Subscribe to:
Posts (Atom)